Apparatus and methods for the treatment of avian influenza with ultrasound

• US 20070219481A1
• Filed: 03/16/2006
• Published: 09/20/2007
• Est. Priority Date: 03/16/2006
• Status: Abandoned Application

• Current Assignee: Eilaz Babaev
• Original Assignee: Eilaz Babaev
• Inventors: Babaev, Eilaz
• Application Number:
  US11/384,155
• Publication Number:
  US 20070219481A1
• Time in Patent Office: Days
• US Class Current: 604/22
• CPC Class Codes: A61M 11/001 Particle size control
• CPC Class Codes: A61M 11/005 using ultrasonics spraying or atomising liquids using ultrasonic vibrations in general B05B17/06
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

The method and device of the present invention for the treatment of avian influenza and other viruses, bacteria, and infectious agents with ultrasonic waves includes a generator and a transducer to produce ultrasonic waves. The ultrasonic transducer has a specially designed ultrasound tip that is able to radiate ultrasound energy toward the body of the target animal or human at a level higher than a traditional ultrasound tip. The apparatus delivers ultrasonic energy without contacting the target through an air/gas medium or through a spray, or by contacting the target with or without a coupling medium. The ultrasonic waves provide a therapeutic effect such as destroying viruses, bacteria, or other infectious agents, increasing blood flow, or stimulating the immune system, etc; additionally, breathing ability is enhanced through the ultrasonic delivery of a medicament to the target'"'"'s lungs.

Claims

1. ) A method for the treatment of avian influenza with ultrasound as well as the ultrasound treatment of other viruses, bacteria, and infectious agents such as human influenza, hepatitis C, etc., comprising the steps of:

a) delivering ultrasonic energy without contacting the target (an animal or human body) through an air/gas medium or through a spray, or by contacting the target with or without a coupling medium such as a liquid, gel, gel pad, etc., wherein the ultrasonic energy has an intensity capable of penetrating the body'"'"'s surface to provide a therapeutic effect such as destroying viruses, bacteria cells, or other infectious agents, increasing blood flow, or stimulating the immune system, etc.;

b) sonicating and energizing the medicament,

c) delivering the medicament droplets through the mouth of the animal or human and into its lungs through an ultrasonic spray to provide a therapeutic effect.

2. ) The method according to claim 1, further including the step of generating the ultrasonic energy with particular ultrasound parameters indicative of an intensity capable of achieving a therapeutic effect.

3. ) The method according to claim 1, wherein the particular amplitude is at least 3 microns.

4. ) The method according to claim 1, wherein the frequency is in the range of 20 kHz-60 MHz.

5. ) The method according to claim 1, wherein the preferred frequency is in the range of 20 kHz-100 kHz.

6. ) The method according to claim 1, wherein the most preferred frequency value is 30 kHz.

7. ) The method according to claim 1, wherein the steps of the method are included in a series of treatments wherein another treatment of the series of treatments is selected from the group consisting of:

delivering ultrasonic energy to the body, wherein the ultrasonic energy has an intensity capable of penetrating the body to provide a therapeutic effect to the body;

sonicating the medicament and delivering the medicament droplets through the mouth of the animal or human and into its lungs through an ultrasonic spray to provide a therapeutic effect;

the treatment including the steps of the method of the invention, wherein a different medicament is utilized.

8. ) The method according to claim 1, wherein the medicament is either:

immunoglobulin, gamma globulin, interferon, an antibiotic, an ointment, cream, gel, liquid, salve, oil, saline solution, distilled, non-distilled and/or boiled water, powder, spray, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient or agent, etc.

9. ) The method according to claim 1, wherein the medicament is applied either before, after, or during delivery of the ultrasonic energy.

10. ) The method according to claim 1, wherein the step of delivering ultrasonic energy includes the step of providing means for delivering the ultrasonic energy through an air/gas medium or through a spray without contacting the animal or human target.

11. ) The method according to claim 1, wherein the step of delivering ultrasonic energy includes the step of providing means for delivering the ultrasonic energy by contacting the animal or human target with or without a coupling medium such as a liquid, gel, gel pad, etc.

12. ) The method according to claim 1, wherein the therapeutic effect provided is the destruction of viruses, bacteria cells, or other infectious agents, the increase blood flow in the body, the stimulation of the immune system, or the enhancement of breathing ability, etc.

13. ) An apparatus for the treatment of avian influenza with ultrasound as well as the ultrasound treatment of other viruses, bacteria, or infectious agents such as human influenza, hepatitis C, etc., comprising:

a) a generator and a transducer for generating ultrasonic energy;

b) wherein the transducer delivers the ultrasonic energy to the body or delivers a medicament to the lungs through the mouth; and

c) wherein the ultrasonic energy has an intensity capable of applying acoustic energy and penetrating the animal or human'"'"'s body to provide a therapeutic effect such as destroying viruses, bacteria cells, or other infectious agents, increasing blood flow, or stimulating the immune system, etc., or of sonicating and energizing the medicament and delivering the medicament droplets through the mouth of the animal or human and into its lungs through an ultrasonic spray to provide a therapeutic effect

14. ) The apparatus according to claim 13, wherein the generator and transducer generate the acoustic energy with particular ultrasound parameters indicative of an intensity capable of achieving a therapeutic effect.

15. ) The apparatus according to claim 13, wherein the particular amplitude is at least 3 microns.

16. ) The apparatus according to claim 13, wherein the frequency is in the range of 20 kHz-60 MHz.

17. ) The apparatus according to claim 13, wherein the preferred frequency is in the range of 20 kHz-100 kHz.

18. ) The apparatus according to claim 13, wherein the most preferred frequency value is 30 kHz.

19. ) The apparatus according to claim 13, wherein the transducer includes a radiation surface having a surface area dimensioned/constructed for achieving delivery of the ultrasonic energy to the animal or human with an intensity capable of achieving a therapeutic effect.

20. ) The apparatus according to claim 13, wherein the transducer includes a radiation surface where the shape of the curvature of the radiation surface is either concave, conical, the concave-convex special design, or another comparable shape intended to achieve delivery of the ultrasonic energy to the animal or human with an intensity capable of achieving a therapeutic effect.

21. ) The apparatus according to claim 13, wherein the shape of the peripheral boundary of the radiation surface is either circular, polygonal, or another comparable shape intended to achieve delivery of the ultrasonic energy to the animal or human with an intensity capable of achieving a therapeutic effect.

22. ) The apparatus according to claim 13, wherein the transducer includes a radiation surface;

a selection is made of a size and of a surface area of the radiation surface, a shape of the peripheral boundary of the radiation surface that is circular, polygonal, or another comparable shape, and a shape of the curvature of the radiation surface that is either concave, conical, the concave-convex special design, or another comparable shape; and

the particular ultrasound parameters of the generated ultrasonic energy for achieving delivery of ultrasonic energy to the animal or human target with an intensity capable of achieving a therapeutic effect.

23. ) The apparatus according to claim 13, wherein the step of delivering ultrasonic energy includes the step of providing means for delivering the ultrasonic energy through an air/gas medium or through a spray without contacting the animal or human target.

24. ) The apparatus according to claim 13, wherein the step of delivering ultrasonic energy includes the step of providing means for delivering the ultrasonic energy by contacting the animal or human target with or without a coupling medium such as liquid, gel, gel pad, etc.

25. ) The apparatus according to claim 13, wherein the transducer is driven by a continuous, pulsed, or modulated frequency and wherein the driving wave form of the transducer is selected from the group consisting of sinusoidal, rectangular, trapezoidal and triangular wave forms.

26. ) The apparatus according to claim 13, wherein the therapeutic effect provided is the destruction of viruses, bacteria cells, or other infectious agents, the increase blood flow in the body, the stimulation of the immune system, or the enhancement of breathing ability, etc.

27. ) The apparatus according to claim 13, wherein the medicament delivered by ultrasound is either:

immunoglobulin, gamma globulin, interferon, an antibiotic, an ointment, cream, gel, liquid, salve, oil, saline solution, distilled, non-distilled and/or boiled water, powder, spray, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient or agent, etc.

28. ) The apparatus according to claim 13, wherein the medicament is applied either before, after, or during delivery of the ultrasonic energy.